Skip to content

A study to evaluate the effectiveness of Nimbpatradi herbal paste in patients with anal fissure

Clinical Evaluation of Nimbpatradi Lepa in Parikartika fissure in ano - nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113585
Enrollment
30
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K602- Anal fissure, unspecified

Interventions

None listed

Sponsors

Rao Zeba
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient willing to sign the consent form. Patient having acute fissure in ano up to 8weeks. Patients with age group between 18 to 60 yrs will be included in the study. Patients having classical features of Parikartika will be selected like Kartanvat Vedana meaning tearing pain, Raktsrava , Daha meaning burning sensation in guda . Controlled case of diabetes mellitus and hypertension.

Exclusion criteria

Exclusion criteria: Pregnancy Patient of chronic fissure in ano will be excluded Patient below 18 yrs and above 60 yrs will be excluded Positive cases of HIV VDRL HCV HBsAg will be excluded Fissure in ano associated with piles and fistula and patients having multiple fissure will be excluded Patient having rectal prolapse Patient with Crohns Disease Ulcerative Colitis Tuberculosis

Design outcomes

Primary

MeasureTime frame
Relief in Subjective Parameters 1. Raktstrava 2. Daha 3. Kandu 4. kartanvad Vedana 5. VibandhTimepoint: Outcome measures will be assessed at baseline Day 0, Day 5, Day 10, and at the end of the treatment period Day 15. Follow up assessments will be conducted twice after completion of the trial, at 15-day intervals, on Day 30 and Day 45.

Secondary

MeasureTime frame
Relief in objective Parameters 1. Sphincter spasm 2. Healing of Ulcer 3. Size of Ulcer 4. Skin Tag 5. Position of UlcerTimepoint: Outcome measures will be assessed at baseline Day 0, Day 5, Day 10, & at the end of the treatment period Day 15. Follow up assessments will be conducted twice after completion of the trial, at 15-day intervals, on Day 30 & Day 45.

Countries

India

Contacts

Public ContactDr Bhoomi Soni

Quadra Institute Of Ayurveda and Hospital Roorkee

bhoomi629@gmail.com9008637659

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026